Morgan Stanley Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $23.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price decreased by Morgan Stanley from $30.00 to $23.00 in a report published on Tuesday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical instruments supplier’s stock.

XRAY has been the topic of a number of other research reports. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Needham & Company LLC cut their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Finally, Mizuho initiated coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $27.91.

DENTSPLY SIRONA Stock Down 1.1 %

Shares of DENTSPLY SIRONA stock opened at $18.47 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market cap of $3.67 billion, a price-to-earnings ratio of -8.92, a PEG ratio of 1.93 and a beta of 0.96. The firm’s 50-day moving average is $20.96 and its two-hundred day moving average is $24.01. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the firm earned $0.49 earnings per share. As a group, research analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.47%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Institutional Trading of DENTSPLY SIRONA

Several large investors have recently made changes to their positions in the business. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the last quarter. Nuance Investments LLC boosted its position in DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after purchasing an additional 402,329 shares in the last quarter. FMR LLC grew its stake in shares of DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after purchasing an additional 436,031 shares during the period. Cooke & Bieler LP increased its holdings in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after buying an additional 1,308,411 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.